Advertisement
News
Advertisement

NuVasive(R) to Participate in Investor Events in March 2013

Tue, 02/19/2013 - 4:30pm
The Associated Press

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that Quentin Blackford, Senior Vice President of Finance and Treasury, is scheduled to present at the following investor events in March 2013:

The Cowen 33rd Annual Health Care Conference at the Boston Marriot Copley Place in Boston, Massachusetts, on Tuesday, March 5, 2013, at 10:00 a.m. EST. Barclays Capital Global Healthcare Conference at the Loews Miami Hotel in Miami, Florida, on Tuesday, March 12, 2013, at 9:00 a.m. EDT.

A live webcast of both presentations will be available online from the investor relations page of the Company's corporate website at www.nuvasive.com. After the live webcasts, a replay of the presentations will remain available on the website for 30 days.

About NuVasive

NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the 4th largest player in the $8.2 billion global spine market. NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic fusion enhancers. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform's lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF®, NuVasive has built an entire spine franchise. With over 80 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus and dedication to outstanding service levels supported by a culture of Absolute Responsiveness®.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading